Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
Sung Jun MaAustin J IovoliGregory M HermannKavitha M PrezzanoElizabeth A RepaskyPublished in: Cancer medicine (2019)
Our NCDB study using propensity score-matched analysis showed a survival benefit for using the longer duration of chemotherapy compared to the shorter duration for both resected stage I-II and unresected stage III pancreatic cancer.